Biotechnology from bench to business

• Follow GEN on:
• Login | Register | Subscribe

• ADME/Tox
• Automation
• Bioprocess Scale-Up
• Bioreactors
• Biosimilars
• Cell Culture
• Cell-Based Assays
• Contract Manufacturing
• Gene Therapy
• High-Throughput Screening
• Immunoassay
• Induced Pluripotent Stem Cells
• Informatics
• Liquid Handling
• Pharmacokinetics
• Protein Characterization
• Protein Detection
• Regenerative Medicine
• RNAi/siRNA
• Stem Cells
• Western Blot

• GEN Articles

• More »

• Feature Articles: Media’s Role in Cell Culture Success
  
• Sidebars: Accelerate Cell-Line Development
  
• Feature Articles: Tying Up Loose Ends in Cell-Line Development
  
• Assay Tutorials: Measuring Drug-Transporter Interactions
  Novel Caco-2 Knockout Cell Lines Accurately Identify Efflux Transporter Interactions
• Corporate Profiles: ATCC Aims to Be More Than a Biorepository
  American Type Culture Collection’s Goal Is to Turn Cells into Value-Added Assets

• Insight & Intelligence™

• More »

• Literature Review: A Step Closer to Personalized Medicine
  May 15, 2013
  Researchers use patient-specific cell lines derived in mice to personalize chemotherapy.
• Cancer Cell Line Identity Crisis
  January 21, 2010
  Researchers weigh in on the impact of incorrectly labeled cell lines on cancer research and drug development.
• Stem Cell Utility Limited by Lack of Ethnic Diversity
  January 15, 2010
  Researchers stress the need to derive new lines that represent populations missing from currently available hESCs.
• Supporters of hESC Research Ecstatic with President Obama’s Executive Order
  March 10, 2009
  NIH guidelines will work for federally funded stem cells, but some say protocols are needed for all cell lines.

• GEN News Highlights

• More »

• New CHO Cell Lines on the Horizon for Hisun
  
• CDI, Coriell Win $26M Toward iPSC Lines, Biorepository
  
• ViaCyte Receives More Funding for Diabetes Stem Cell Therapy
  
• Horizon Deal Supports Boehringer Ingelheim Drug Discovery
  
• Evotec Acquires Cell Supplier
  

• BLOG Biotech

• More »

• Tips on Maintaining High Standards in Cell Culture: How to Avoid the Spreading Problem of Cell Line Contamination
  
• Informed Consent or Not, Tissue Donors Do Not Have Commercial Rights
  

• New Products

• More »

	STEMCELL Technologies CHO Cell Cloning The ClonaCell™-CHO ACF supplement improves cloning efficiency of CHO cells during cell-line development. The challenges of low cloning efficiency can result in significant waste of time and resources during single-cell cloning. The ClonaCell-CHO AC
	Cellectis bioresearch Cell-Line Customization Service Gene customization experts can modify cell lines at any gene, at any position. Services available include gene modification, knock-out, and targeted transgene integration. Thirteen years of genome customization expertise, TALEN™ technology, and IP
	HumanZyme Dendritic Cell Generation The HumanKine G4 dendritic cell generation kit can yield DCs from peripheral blood mononuclear cells with no medium changes. This protocol is enabled by HumanKine GM-CSF and HumanKine IL-4, which are included in the kit and produced in a human cell
	Cellectis bioresearch iPS Cell Lines The iPS Engineering Hub™ service can provide users with customized iPS cell lines engineered with TALEN™ technology. Donated somatic cells are reprogrammed by means of co-expressing four factors (Oct-4, SOX2, c-Myc, and Klf-4) by nonintegrating tec